TETRAPHASE PHARMACEUTICALS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
Revenues
Revenue
Product Revenue, net
License and Collaboration Revenue
Government Revenue
Total revenue
Expenses:
Cost of revenue
Product Revenue, net
Intangible asset amortization
Research and development
General and administrative
Total operating expenses
Selling, general and administrative
Total expenses
Loss from operations
Other income and expenses
Other income (expense)
Loss on extinguishment of debt
Other income
Interest income
Interest expense
Net loss
Net loss per share-basic and diluted
Weighted-average common shares used in net loss per share-basic and diluted
Comprehensive loss

Comments